Viewing Study NCT03497598



Ignite Creation Date: 2024-05-06 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 12:44 PM
Study NCT ID: NCT03497598
Status: TERMINATED
Last Update Posted: 2020-09-02
First Post: 2018-04-05

Brief Title: Preventing Recurrent Urinary Tract Infections With α-D-mannose
Sponsor: Kantonsspital Aarau
Organization: Kantonsspital Aarau

Study Overview

Official Title: Preventing Recurrent Urinary Tract Infections With α-D-mannose a Prospective Randomized Double-blinded Placebo-controlled Trial
Status: TERMINATED
Status Verified Date: 2020-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: not enough patients
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PUTIM
Brief Summary: In this trial women with history of recurrent urinary tract infections UTIs will be followed over the course of 6 months The women will be randomized either to D- Mannose or Placebo

The primary objective of this study is to investigate if treatment with D-mannose reduces the risk for a UTI recurrence compared to treatment with Placebo

H0 Women with history of recurrent UTIs treated with D-Mannose on average have the same number of recurrent UTIs over the course of 6 months compared to women treated with Placebo

H1 Women with history of recurrent UTIs treated with D-Mannose on average have fewer recurrent UTIs over the course of 6 months compared to women treated with Placebo
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: None